Target Price | $16.32 |
Price | $2.95 |
Potential |
453.22%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Fortress Biotech, Inc. 2026 .
The average Fortress Biotech, Inc. target price is $16.32.
This is
453.22%
register free of charge
$27.30
825.42%
register free of charge
$4.04
36.95%
register free of charge
|
|
A rating was issued by 9 analysts: 8 Analysts recommend Fortress Biotech, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Fortress Biotech, Inc. stock has an average upside potential 2026 of
453.22%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 57.68 | 87.43 |
31.75% | 51.57% | |
EBITDA Margin | -186.93% | -49.00% |
18.55% | 73.79% | |
Net Margin | -96.90% | -48.59% |
19.25% | 49.85% |
4 Analysts have issued a sales forecast Fortress Biotech, Inc. 2025 . The average Fortress Biotech, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Fortress Biotech, Inc. EBITDA forecast 2025. The average Fortress Biotech, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Fortress Biotech, Inc. Analysts have issued a net profit forecast 2025. The average Fortress Biotech, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.69 | -1.43 |
68.24% | 46.84% | |
P/E | negative | |
EV/Sales | 0.77 |
4 Analysts have issued a Fortress Biotech, Inc. forecast for earnings per share. The average Fortress Biotech, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Fortress Biotech, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 21 2025 |
Roth MKM |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 21 2025 |
Locked
Roth MKM:
Locked
➜
Locked
|
Mar 11 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 18 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.